Medline Selects NICE to Implement Sales Compensation, Territory and Quota Management

NICE’s Sales Performance Management (SPM) cloud-based solution to manage planning and execution of sales compensation for over 1,600 direct sales representatives across the United States

NICE announced that Medline has selected NICE’s cloud-based Sales Performance Management (SPM) solution to handle territory, quota and sales compensation planning and management for more than 1,600 direct sales representatives selling 550,000+ medical devices and support services. The NICE SPM unified solution for Medline will include NICE Territory & Quota Management (TQM) and NICE Incentive Compensation Management(ICM).

Medline chose NICE SPM because it delivers a unified, natively integrated, planning-to-execution solution, which encompasses territories, quotas, compensation, reporting and forecasting. Key factors in choosing NICE SPM were its ability to handle the performance requirements of high transaction volume, the flexibility to handle complex business rules and the capability to accommodate frequent changes.

“NICE listened to what was important to us to resolve our current pain points and also support our future direction and growth,” said Paul Dudzik, SVP of Sales Operations at Medline. “Just as we do in our work to power healthcare performance, NICE is building working relationships with our whole team and proving to be a dedicated partner for our business success.”

“We are pleased that Medline chose our SPM solution to handle their territory management, quota management and sales compensation needs as a unified solution,” said Barry Cooper, President of the Enterprise Group for NICE. “It is a testament to our solution’s ability to provide a bridge between SPM planning and execution processes, while maintaining real-time performance and scalability and delivering a seamless user experience for a broad range of stakeholders in the enterprise.”

ICMNewsNICEPaul DudzikQuota ManagementQuote & ProposalSales compensationSPMTerritory
Comments (0)
Add Comment